Valve Science Center

Valvular Heart Disease: A Growing and Undertreated Condition

More than 3.2 million people have been diagnosed with valvular heart disease in the United States. That number is expected to increase to 5.6 million by 2030. The vast majority, however, are not receiving adequate care, but instead receive conservative therapy or “watchful waiting” without diligent monitoring. Currently, those diagnosed with symptomatic valvular disease have a median survival rate of only one to two years.

Working to Save and Change Lives

The Minneapolis Heart Institute Foundation® (MHIF) Valve Science Center is working to improve outcomes for patients with valvular heart disease. As a leader in understanding valve disease, innovating therapies and identifying best in class care model solutions, the MHIF Valve Science Center:

  • Studies the barriers to care for the undertreated population of patients with valvular heart disease;
  • Designs, develops and implements novel guideline-based patient care pathways;
  • Expands the delivery of high-quality, state-of-the-art care for valvular patients; and
  • Educates the public on the needs of this population and the opportunities for improvement in their care.

The MHIF Valve Science Center leads the industry in minimally invasive, non-surgical valve repair and replacement. Thousands of patients with degenerative valve disease are not candidates for conventional heart surgery due to their age or other health issues. And as health care is transformed to improve outcomes, finding effective treatments which offer quicker recovery times is critical. Consider a gift to the MHIF Valve Science Center today.

Collaborating and Educating to Impact Global Outcomes

Researchers at MHIF partner with medical device manufacturers and medical colleagues to provide those with valve disease new treatment options that ideally improve quality of life. MHIF leads the industry in transcatheter aortic valve replacement (TAVR) and transcatheter aortic valve implantation (TAVI) procedures. MHIF’s expertise is widely shared at industry conferences, and brought cardiologists from around the world to our 2014 Valve Summit.

 

“VALVULAR HEART DISEASE IS A PUBLIC HEALTH CRISIS.”

— Dr. Paul Sorajja